Melatonin Prolonged-Release May Improve Insomnia and Depression in Epilepsy Patients
Journal of Epilepsy Research · 10.06.2026 · 16 (1) · 36-40
DOI: 10.14581/jer.26006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Epilepsy Research, online erschienen am 10.06.2026. Verfasst von Dong Won Kwack und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Konkuk University Medical Center, Seoul, Korea. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression, Schlaf
Abstract (Originalsprache)
Background and Purpose: Insomnia is a common sleep disorder that is highly prevalent among patients with epilepsy. Despite the known benefits of melatonin for insomnia and its potential anticonvulsive effects, clinical evidence regarding its efficacy in epilepsy patients with comorbid insomnia remains limited. This pilot study aimed to evaluate the efficacy and safety of prolonged-release (PR) formulation of melatonin in epilepsy patients with insomnia.
Methods
We prospectively enrolled 34 adult patients with epilepsy from March 2024 to February 2025. The insomnia severity index (ISI) and the Korean version of the Neurological Disorders of Depression Inventory for Epilepsy (K-NDDI-E) were assessed before and after 12 weeks of melatonin PR intake. Data were analyzed using the Wilcoxon signed-rank test. Changes in seizure status before and after treatment were analyzed using McNemar’s test.
Results
A total of 25 patients (nine males, mean age 53.5±11.6 years) completed the study. Of these, 23 had focal-onset seizures and two had generalized-onset seizures. After 12 weeks of treatment, ISI scores significantly improved from 16.0±4.4 to 12.2±5.2 (p=0.001). Similarly, K-NDDI-E scores showed a significant reduction from 11.3±4.2 to 9.8±3.2 (p=0.041). Seizure status remained unchanged following treatment, with no statistically significant difference observed before and after melatonin PR administration (p=1.000). No patients discontinued the medication due to seizure aggravation.
Conclusions
Our findings demonstrate that melatonin PR effectively improves both sleep quality and depression in epilepsy patients with insomnia. These results suggest that melatonin PR could be a potential therapeutic option for managing comorbid insomnia and depression in patients with epilepsy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Konkuk University Medical Center, Seoul, Korea.
Zitieren
APA
Kwack, D. W., & Kim, D. W. (2026). Melatonin Prolonged-Release May Improve Insomnia and Depression in Epilepsy Patients. Journal of Epilepsy Research, 16(1), 36-40. https://doi.org/10.14581/jer.26006
Vancouver
Kwack DW, Kim DW. Melatonin Prolonged-Release May Improve Insomnia and Depression in Epilepsy Patients. Journal of Epilepsy Research. 2026;16(1):36-40. doi:10.14581/jer.26006
BibTeX
@article{Kwack2026,
author = {Kwack, Dong Won and Kim, Dong Wook},
title = {Melatonin Prolonged-Release May Improve Insomnia and Depression in Epilepsy Patients},
journal = {Journal of Epilepsy Research},
year = {2026},
volume = {16},
number = {1},
pages = {36--40},
doi = {10.14581/jer.26006}
}
EUVIMED